Dermatology and Hair Restoration: The Workup Before Surgery

Dermatology and Hair Restoration: The Workup Before Surgery

Introduction: What Should Happen Before a Hair Transplant Is Ever Discussed

The companion article, “Where One Ends, One Begins,” examined the conceptual boundary between dermatology and hair restoration. This article covers the clinical side: the protocol that should take place before surgery is ever recommended.

The principle is simple. Effective hair loss treatment begins with finding the cause. An accurate diagnosis typically requires a board-certified physician, often a dermatologist, with in-depth knowledge of the many conditions that cause hair loss. Thinning hair is a symptom, and a symptom alone cannot determine whether a transplant is appropriate.

A thorough pre-surgical workup rests on four pillars:

  1. History-taking: a structured conversation about onset, pattern, family history, health, and medications
  2. Physical examination: including the pull test and trichoscopy
  3. Targeted laboratory testing: ordered when clinical findings call for it
  4. Scalp biopsy: used when the diagnosis remains uncertain

Androgenetic alopecia, or pattern hair loss, is by far the most common cause. It affects an estimated 50 million men and 30 million women in the United States and accounts for more than 95% of hair loss cases in men. Procedure-focused clinics often cite that figure as a reason to skip diagnosis. Instead, it should be a diagnosis that gets confirmed, not assumed.

The stakes are real. Roughly 6.3% of patients seeking restoration have hair loss driven by medical, hormonal, or medication-related causes. A transplant would not fix those problems and could make some of them worse. For these patients, the diagnosis decides whether surgery is appropriate or inappropriate.

Step One: Medical and Family History

Diagnosis starts with a conversation, before any exam. A careful physician will ask about:

  • Onset and pattern: whether the loss was sudden or gradual, and whether it is diffuse, patchy, or concentrated at the hairline and crown
  • Family history: pattern baldness in parents, grandparents, or siblings
  • Recent illness: high fevers, surgery, major infections, or significant weight loss
  • Medications: including new prescriptions, discontinued drugs, and supplements
  • Diet and nutrition: restrictive eating, vegetarian or vegan diets, and other possible deficiencies
  • Stress events: major life changes in the months before shedding began
  • Menstrual and hormonal history: for women, cycle regularity, pregnancy, postpartum changes, menopause, and hormonal contraception

These details carry clinical weight. Timing and distribution often separate androgenetic alopecia from telogen effluvium or alopecia areata before any test is run. Gradual thinning at the temples and crown with a strong family history points one way. Sudden diffuse shedding three months after a serious illness points another. Round, smooth patches point toward a third diagnosis.

History acts as the first filter. It separates patients who are likely straightforward surgical candidates from those who need more medical evaluation first.

Step Two: The Physical and Scalp Exam

The hands-on exam is the second pillar. The physician inspects the scalp, hairline, and density pattern, including the donor area at the back and sides of the head. Two diagnostic tools add precision: the pull test and trichoscopy.

The Pull Test: Quantifying Active Shedding

In a pull test, the physician gently grasps a small section of hair, roughly several dozen strands, and pulls lightly to see how many come out. The test is repeated in several zones of the scalp.

Normally only a few hairs release. A higher count suggests an active process such as telogen effluvium or alopecia areata, not stable pattern thinning.

This matters a great deal before surgery. Transplanting into a scalp with active, undiagnosed shedding risks poor graft survival. It also does nothing to stop continued loss in the native hair around the transplant, which can leave an unnatural result as surrounding hair keeps thinning.

Trichoscopy: Magnified Analysis of Hair and Scalp

Trichoscopy is a dermoscopic examination: a magnified, in-office look at the scalp surface and hair shafts. It shows patterns that cannot be seen with the naked eye, and it reveals findings such as:

  • Variation in hair shaft diameter: Miniaturization, where affected follicles produce progressively finer hairs, is a hallmark of androgenetic alopecia.
  • Yellow dots and exclamation-point hairs: These suggest alopecia areata.
  • Perifollicular scaling or loss of follicular openings: These are red flags for scarring alopecia, including central centrifugal cicatricial alopecia (CCCA).

Because trichoscopy is non-invasive and quick, it can often narrow the diagnosis before any blood work or biopsy is ordered.

Step Three: Targeted Laboratory Testing

When history or exam suggests an underlying disease, vitamin deficiency, hormone imbalance, or infection, blood work can confirm or rule out systemic causes. Many practices can arrange this testing in the office.

The medical literature does not fully agree on which tests every hair loss patient needs. For that reason, testing should follow the clinical findings and not be run as a reflexive panel. The tests below are among the most commonly considered.

Ferritin: Screening for Iron-Deficiency-Related Shedding

Ferritin is a marker of the body’s stored iron. Low ferritin has been linked to telogen effluvium, especially in women.

Research supports this link. Women with hair loss show significantly lower serum ferritin than women without it. One study proposed about 40 ng/mL as a practical threshold. A later case-control study found mean ferritin of about 16 ng/mL in telogen effluvium patients compared with roughly 60 ng/mL in controls.

The clinical implication is direct. Finding low ferritin can steer a patient toward correcting a deficiency instead of pursuing surgery that would not address the root cause.

TSH and Thyroid Function

Thyroid-stimulating hormone (TSH) is routinely included in initial hair loss workups because thyroid disease is known to be associated with diffuse shedding.

There is an important caveat. Observational studies have not clearly shown a direct association between TSH levels and hair loss. TSH is one data point among several, not a standalone answer.

This kind of interpretation is where physician expertise adds value over self-ordered lab panels. A number on a lab report means little until someone places it in the context of the patient’s history, exam, and other results.

Hormone Panels

Broader hormone testing is used when the picture suggests androgen excess, irregular menstrual cycles, or other endocrine involvement. This is especially relevant for women with pattern hair loss.

The aim is to tell straightforward androgenetic alopecia apart from hair loss that signals a broader condition. Research has noted that androgenetic alopecia can sometimes point to underlying endocrine or systemic disease.

Finding a hormonal driver can change the whole treatment sequence. In those cases, medical management comes first, before any discussion of surgical restoration.

Step Four: When a Scalp Biopsy Is Required

Sometimes history, exam, and labs still cannot answer the most important pre-surgical question: Is this scarring or non-scarring alopecia? A scalp biopsy settles it.

A biopsy is a brief in-office procedure. The physician removes a small sample of scalp tissue, and a pathologist examines it under a microscope to assess follicle structure, inflammation, and signs of scarring.

Scarring vs. Non-Scarring Alopecia: Why the Distinction Is Decisive

Non-scarring alopecia includes androgenetic alopecia, telogen effluvium, and alopecia areata. In these conditions the follicles remain structurally intact. They can regrow hair, or support transplantation, once the underlying cause is managed.

Scarring alopecia, also called cicatricial alopecia, is different. Inflammation permanently destroys the follicles and replaces them with scar tissue. Central centrifugal cicatricial alopecia (CCCA) is a prominent example, and it is best evaluated by a dermatologist. It typically starts at the crown and spreads outward over time.

The surgical implications are clear. Active inflammatory or scarring disorders, diffuse thinning in the donor area, certain autoimmune conditions, and unstable hair loss may all need treatment or further evaluation before surgery is considered. Transplanting grafts into active scarring disease sets the procedure up to fail, because the same inflammation that destroyed the original follicles can destroy the transplanted ones.

Biopsy findings can also confirm diagnoses such as alopecia areata. In that condition, surgical candidacy depends on disease stability, not on aesthetic preference.

Matching the Diagnosis to the Right Pathway

A completed workup does not put every patient into one “hair loss” category. It sorts them into distinct clinical groups, each with its own appropriate pathway.

Androgenetic Alopecia: The Most Common Surgical Candidate

Androgenetic alopecia affects an estimated 85% of men and 40% of women at some point in their lives. Roughly 50% of men show evidence of it, and up to 13% of premenopausal women do as well.

It drives the large majority of restoration cases, about 81.1% of patients. Even so, what makes a patient an appropriate transplant candidate is a confirmed, stable diagnosis with an adequate donor supply. An assumed diagnosis is not enough.

Telogen Effluvium: A Condition to Treat, Not Transplant

Telogen effluvium causes diffuse shedding that is often reversible. Common triggers include illness, stress, and nutritional deficiency, especially low ferritin.

Surgery is inappropriate during active telogen effluvium. The right approach is to identify and correct the trigger first. In many cases the hair recovers on its own once the cause is resolved.

Alopecia Areata: An Autoimmune Diagnosis With Its Own Treatment Path

Alopecia areata is an autoimmune condition. It is identified through history and trichoscopy findings such as exclamation-point hairs, and it is a separate disease from pattern baldness.

Since 2022, the FDA has approved three JAK inhibitors for severe alopecia areata:

  • Baricitinib (Olumiant): the first oral drug approved specifically for the disease
  • Ritlecitinib (Litfulo)
  • Deuruxolitinib (Leqselvi)

These medications are not approved for androgenetic alopecia or ordinary telogen shedding. Whether they are appropriate depends entirely on getting the diagnosis right before a treatment path is chosen.

CCCA and Other Scarring Alopecias: A Surgical Contraindication Until Controlled

CCCA is a biopsy-confirmed, progressive scarring condition. While it is active, it must be controlled medically, not addressed surgically.

Recommending a transplant for an active scarring case without biopsy confirmation is one of the clearest clinical errors a procedure-first provider can make.

Why This Workup Is the Gatekeeper for Surgical Candidacy

Every step in this sequence leads to one outcome. A thorough assessment that starts with diagnosis determines not only whether someone needs a procedure, but whether a procedure is medically appropriate at all.

That role is growing more important. Industry data show patients increasingly seek treatment before hair loss reaches advanced stages. More people now approach restoration as a planned, proactive medical decision instead of a last resort. Earlier intervention makes an accurate baseline diagnosis more consequential, because treatment decisions made at that stage shape outcomes for years.

Premium providers are also adding digital imaging and AI-assisted scalp analysis to the clinical exam. In 2026, roughly 40% of advanced clinics are expected to use at least one AI-assisted planning or assessment technology. Used well, these tools support physician judgment. They do not replace it.

Red Flags: Recognizing a Procedure-First “Hair Mill”

Patients comparing providers should watch for these warning signs:

There is a structural reason these practices exist. No ABMS-recognized board certification exists for hair transplant surgery. There are no accredited residencies or fellowships dedicated to the procedure. In many jurisdictions, any licensed physician can legally perform transplants regardless of specialty training. Because of this, the diagnostic protocol, not the marketing, is what truly separates providers.

The consequences of skipping diagnosis are serious. They include misdiagnosis, missed systemic disease that the hair loss was signaling, and surgery that was unnecessary or ill-advised.

The Shapiro Medical Group Standard: Diagnosis Before Any Surgical Recommendation

The protocol described above reflects how Shapiro Medical Group approaches each patient. Evaluation at the Minneapolis practice is led by board-certified physicians and is not delegated to sales staff or technicians.

The practice has focused exclusively on hair restoration since 1990. Dr. Ron Shapiro co-authored the field’s leading textbook, which physicians often call the “Hair Transplant Bible.” The medical team has lectured at more than 100 conferences in over 20 countries. Physicians from other practices come to Shapiro Medical Group both to learn advanced techniques and to have their own procedures performed. That depth of experience is what it takes to interpret history, exam findings, lab results, and biopsy reports correctly.

The practice’s one-patient-per-day policy supports this rigor. Careful history-taking, a thorough examination, and thoughtful review of findings require unhurried time with a physician. A rushed sales consultation cannot provide that.

Shapiro Medical Group also offers a full range of options. Surgical treatments include FUE and FUT, which can be combined to maximize graft yield. Non-surgical treatments include scalp micropigmentation (SMP), regenerative therapies, and medical therapies that improve and maintain hair growth. Because of this range, a diagnosis can lead to the right pathway, including non-surgical treatment, and a transplant is never the only service on offer.

Conclusion: Diagnosis Is the Procedure That Comes Before the Procedure

A rigorous pre-surgical evaluation includes history, pull test, trichoscopy, targeted labs, and biopsy when indicated. This workup is what separates appropriate surgical candidates from patients who need medical treatment first.

Whether a practice performs this workup is the clearest sign of whether it is a diagnosis-led practice or a procedure-first hair mill. Informed patients are better-protected patients. With this checklist in mind, readers can ask the right questions before committing to any provider:

  • Who performs the evaluation?
  • What tests are being considered, and why?
  • Has scarring alopecia been ruled out?

Schedule a Comprehensive Diagnostic Consultation

Shapiro Medical Group invites prospective patients to start with an evaluation, not a procedure sale. Consultations are physician-led and grounded in the diagnostic principles outlined in this article, so the cause of hair loss is understood before any surgical recommendation is made.

The practice welcomes patients from Minnesota, from across the United States, and from abroad. It has long-standing experience coordinating care for patients who travel for treatment.

To begin, readers can request a consultation through the Shapiro Medical Group website at shapiromedical.com.

Facebook
Twitter
LinkedIn
Other Post You may like
Doctor and patient discussing dermatology and hair restoration consultation in bright office

Dermatology and Hair Restoration: The Workup Before Surgery

Before a hair transplant is ever recommended, a proper dermatology and hair restoration workup should confirm the true cause of hair loss. This article breaks down the four-pillar diagnostic protocol—history, physical exam, lab testing, and biopsy—that separates evidence-based care from procedure-first clinics.

Read More